AstraZeneca AstraZeneca/Merck hope for expanded ovarian cancer drug use SOLO-1 results back use in first-line maintenance therapy
News Tesaro stock rockets as rumours of Roche takeover abound Shares in US biotech Tesaro peaked this week amid speculation that Roche is making plans to buy it.
News Roche to buy rest of genetics firm Foundation Medicine Roche has made an offer to buy the remaining shares in cancer genetics firm Foundation Medicine (FMI) for $2.4 billion.
News NICE says 'no' to Roche's Perjeta after breast cancer surger... NICE consulting on first draft decision
News FDA approves Keytruda in cervical cancer Merck & Co’s blockbuster Keytruda has been approved in advanced second line cervical cancer, becoming the first drug in its class approved in the indication.
News Curium strikes $8bn deal to buy radiopharma rival Lantheus Two players in the radiopharma sector, Curium and Lantheus, have agreed to merge and create an end-to-end player in diagnostics and therapeutics.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
